April Quiz

1. What trace element is not currently recommended to be included in MTE products for use in PN? A. Manganese B. Zinc C. Iron D. Copper

2. Which of the following is a commercially available MTE product in the United States that adheres to the ASPEN recommendations? A. Multitrace-5 B. Tralement C. Addamel N\ D. No such product exists

3. A 56-year-old female is admitted with abdominal pain secondary to necrotizing pancreatitis and started on PN. She reports eating little to nothing for over a week and is determined to be at risk for refeeding syndrome. Which of the following should be administered to prevent complications from refeeding? A. Cyanocobalamin B. Thiamine C. Ascorbic acid D. Vitamin E

4. Which of the following commercially available multivitamin product(s) are currently on the market that adhere(s) to the ASPEN dose recommendation? A. M.V.I Adult B. M.V.I-12 C. Infuvite D. a and c

5. Which of the following is not recommended during a national shortage of adult MVI or MTE products? A. Assess the indication for PN B. Administer oral supplements if able or tolerated C. Compound PN with appropriately dosed individual injectable components

Use pediatric formulations 6. Factor leading to ASPEN recommending an MTE commercial product be made without chromium: A. Multiple cases of symptomatic toxicity while on

PN

B.

C. High levels of chromium contaminating other PN components High levels of carcinogenic versions of chromium in PN

D. Chromium is not necessary for functions within the body

7. Parkinsonian-like tremor is a sign of neurotoxicity due to _____ toxicity: A. Thiamine B. Manganese C. Zinc D. Copper

8. The recommended dose of selenium was ____ to _____ mcg by ASPEN in 2012 A. Increased; 20-60 B. Increased; 60-100 C. Decreased; 20-60 D. Decreased; 60-100

9. Why are parenteral water-soluble vitamin doses in PN higher than oral RDA doses? A. Increased urinary excretion B. Patients at increased risk of deficiency or malnutrition

C. D. Decreased bioavailability a and b

10. Concerns have been raised about the daily dose adequacy in MVIs of what fat-soluble vitamin? A. Vitamin A B. Vitamin D C. Vitamin E D. Vitamin K